# Progress Note 03 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Mark Twain (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI013-SYN-TD
- Date: 1905-07-17
- Fictional facility: St. Posthumous Health Center
- Fictional author: Winifred Achterberg-Lowe, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Five-week review: the CT coronary angiogram, smoking, gout and grief. **S**

## History of present illness

Mr. Clemens returns five weeks after intake. He has had four grief therapy sessions; he has told the story of his wife's last evening, held an imaginal conversation with her, and looked through one photograph album. He sleeps about five hours. The passing thoughts of joining her have not come in the last two weeks. He had chest tightness once more, three weeks ago, walking fast up a steep hill, gone within three minutes of stopping. The CT coronary angiogram this morning showed a calcium score of 410 and a 25 to 49 percent narrowing of the main artery at the front of the heart, with no blockage. He smokes about eight cigars a day. Having seen the pictures of his arteries, he says he is ready to try to stop. He had a twinge in the right big toe last week that settled in a day. **S**

| Element | Detail |
|---|---|
| Grief therapy | Four sessions; PG-13-R 37 |
| Safety | No thoughts of death for two weeks |
| Chest | One episode three weeks ago on a steep hill |
| CT coronary angiogram | Calcium score 410; CAD-RADS 2, nonobstructive |
| Tobacco | About eight cigars a day; ready to quit |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy a little better |
| Cardiovascular | Positive | One episode of exertional chest tightness three weeks ago; none at rest |
| Musculoskeletal | Positive | A brief twinge in the right big toe last week |
| Psychiatric | Positive | Grief still heavy but more bearable; no thoughts of death |

4 systems reviewed. **S**

## Current medications

- Varenicline 0.5 mg oral tablet: one tablet daily for three days, then one tablet twice daily for four days **S**
- Atorvastatin 40 mg oral tablet, one tablet daily **S**
- Aspirin 81 mg delayed-release oral tablet, one tablet daily **S**
- Allopurinol 100 mg oral tablet, one tablet daily **S**
- Colchicine 0.6 mg oral tablet, one tablet daily for flare prevention while allopurinol is started, for three to six months **S**

## Allergies

- No known allergy **S**

## Objective

BP 136/80 mmHg; pulse 78 bpm; respirations 16/min; temperature 36.6 °C; oxygen saturation 96% on room air; weight 64.1 kg; BMI 21.4 kg/m². All vital signs are synthetic.

PHQ-9: 9. All results are synthetic.

## Change since baseline

- PHQ-9: 11 at baseline, 9 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 136/80, pulse 78; weight 64.1 kg |
| Cardiovascular | Regular rhythm; no murmur; peripheral pulses normal |
| Musculoskeletal | Right first toe joint not swollen or tender; no tophi |
| Psychiatric | Brighter; talks about his wife with some warmth as well as pain |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Nonobstructive coronary artery disease** (I25.10). CAD-RADS 2 with a calcium score of 410: coronary atherosclerosis without a narrowing that limits blood flow, which fits his brief, infrequent exertional tightness. The 1902 chronic coronary disease guideline calls for a high-intensity statin, low-dose aspirin, blood pressure below 130/80 mmHg and stopping smoking; no functional testing is needed while symptoms stay infrequent. **S**
   - Atorvastatin 40 mg daily, with a lipid panel and ALT in about eight weeks.
   - Aspirin 81 mg daily.
   - Walk daily at a pace that allows talking; call 911 for chest pain at rest or lasting more than fifteen minutes.
2. **Tobacco use disorder** (F17.290). Ready to quit after seeing his CT. Varenicline is the most effective single medicine and is safe in stable coronary disease; counseling adds to it. **S**
   - Varenicline 0.5 mg daily for three days, then twice daily, then 1 mg twice daily from day eight, for twelve weeks.
   - Quit date in the second week.
   - Counseling at each visit and the state quitline.
3. **Gout** (M10.9). Urate 8.6 mg/dL with two flares in the past year: urate-lowering therapy is strongly recommended by ACR 1899. eGFR 74. HLA-B*58:01 testing is not indicated by his ancestry. **S**
   - Allopurinol 100 mg daily, raised by 100 mg every two to five weeks to a urate below 6 mg/dL.
   - Colchicine 0.6 mg daily for three to six months to prevent flares.
   - Urate in three to four weeks.
   - If a flare comes, keep taking allopurinol and call.
4. **Prolonged grief disorder** (F43.81). PG-13-R 37 and PHQ-9 9 after four sessions. Safety reviewed: no thoughts of death for two weeks. **S**
   - Continue weekly grief therapy; telephone sessions while he travels in August.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Grief severity (PG-13-R) and the DSM-5-TR prolonged grief disorder criteria | At diagnosis and every four weeks during therapy | Completed today | PG-13-R 37 |
| Referral | Prolonged grief disorder therapy: sessions attended | Weekly for sixteen weeks | Completed today | Four of four sessions attended |
| Survey | Depression (PHQ-9), to watch for major depression | At baseline and every four weeks during treatment | Completed today | PHQ-9 9, item 9 scored 0 |
| Survey | Suicide risk review, safety plan, means safety and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of death for two weeks; safety plan kept |
| Self-management | Sleep, without sedative-hypnotics | Every visit | Completed today | About five hours |
| Self-management | Social contact and his writing | Every visit | Completed today | Two visits with friends; started writing again for an hour most mornings |
| Self-management | Tobacco use (cigars a day), readiness and counseling | Every visit | Completed today | About eight cigars a day; ready to quit; varenicline started |
| Medication safety | Varenicline: adherence, nausea, sleep and mood changes | Every visit | Not indicated | Starting today |
| Examination | Chest symptoms on exertion | Every visit | Completed today | One episode three weeks ago on a steep hill; none at rest |
| Imaging | CT coronary angiography for stable exertional chest tightness | Once, at evaluation | Completed today | Calcium score 410; CAD-RADS 2 (25 to 49 percent proximal left anterior descending); no obstructive disease |
| Examination | Blood pressure | Every visit | Completed today | 136/80 mmHg; target below 130/80 |
| Laboratory | Lipid panel and ALT on a statin | 4 to 12 weeks after starting, then every 3 to 12 months | Ordered | Baseline LDL 150 mg/dL and ALT 24 U/L at intake; repeat in about eight weeks |
| Laboratory | Serum urate during allopurinol titration | Every 2 to 5 weeks while titrating, then every 6 months | Ordered | Baseline 8.6 mg/dL; repeat three to four weeks after starting allopurinol |
| Self-management | Gout flares and colchicine prophylaxis | Every visit | Completed today | A one-day twinge last week; colchicine started with allopurinol |

## Goal progress

- PG-13-R below 30 and back to writing and seeing friends. In progress; target 1905-10-16. **S**
- No thoughts of death and a safety plan he would use. In progress; target 1905-09-11. **S**
- Stop smoking cigars. In progress; target 1905-10-16. **S**
- LDL cholesterol at least 50 percent lower on a high-intensity statin. In progress; target 1905-09-11. **S**
- Serum urate below 6 mg/dL and no gout flares. In progress; target 1905-10-16. **S**
- Six or more hours of sleep on most nights without a sleeping pill. In progress; target 1905-10-16. **S**

## Medication changes

- Started: Varenicline 0.5 mg oral tablet: one tablet daily for three days, then one tablet twice daily for four days **S**
- Started: Atorvastatin 40 mg oral tablet, one tablet daily **S**
- Started: Aspirin 81 mg delayed-release oral tablet, one tablet daily **S**
- Started: Allopurinol 100 mg oral tablet, one tablet daily **S**
- Started: Colchicine 0.6 mg oral tablet, one tablet daily for flare prevention while allopurinol is started, for three to six months **S**

## Guideline basis

- Prolonged Grief Disorder (DSM-5-TR criteria, patient and family information) (2022), American Psychiatric Association
- Validation of the new DSM-5-TR criteria for prolonged grief disorder and the PG-13-Revised (PG-13-R) scale (2021), World Psychiatry 2021;20(1):96-106 (Prigerson HG et al.)
- Treatment of complicated grief: a randomized controlled trial (2005), JAMA 2005;293(21):2601-8 (Shear K et al.)
- Optimizing Treatment of Complicated Grief: A Randomized Clinical Trial (2016), JAMA Psychiatry 2016;73(7):685-94 (Shear MK et al.)
- Loss of partner and suicide risks among oldest old: a population-based register study (2004), Age and Ageing 2004;33(4):378-83 (Erlangsen A et al.)
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021), U.S. Preventive Services Task Force
- 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain (2021), American Heart Association and American College of Cardiology (Circulation 2021;144(22):e368-e454)
- 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023), American Heart Association and American College of Cardiology (Circulation 2023;148(9):e9-e119)
- 2020 American College of Rheumatology Guideline for the Management of Gout (2020), American College of Rheumatology (Arthritis Care & Research 2020;72(6):744-760)
- CMID: Clinical Monitoring Intelligence Database, ischemic heart disease, hyperlipidemia, and depression, bipolar, and mood disorders monographs (2026), Aether Forge

## Follow-up

- Telephone check in two weeks. Urate blood test in three to four weeks. Thirteen-week review in September, after his August trip. Call the clinic or 988 at any time. **S**
- Next scheduled visit 1905-09-11: thirteen-week review: grief therapy, smoking, a gout flare while away, the urate and lipid results. **S**
